Previous studies have reported that the protein expression of TREM2 was significantly decreased in Aβ-injected mice [73] or lipopolysaccharide-stimulated APP/PS1 mice [74], suggesting that the level of the TREM2 protein gradually decreases with continuous neuroinflammatory toxicity in AD. This evidence concerns the gene APP and Alzheimer disease.